10x Genomics is trading at $81.03, up 7.15%, with no confirmed catalyst for the rebound.
- No clear company-specific announcement was reported on September 24.
- The move reverses the 6.29% decline recorded on September 23.
- Recent coverage references earlier optimism around raised 2026 guidance and Atera demand, while biotech stocks and major indexes are weaker.